Gene expression profiling for the identification, monitoring, and treatment of prostate cancer

Details for Australian Patent Application No. 2010203825 (hide)

International Classifications

Event Publications

21 July 2011 PCT application entered the National Phase

PCT publication WO2010/080702 Priority application(s): WO2010/080702

2 February 2012 Assignment before Grant

Source Precision Medicine, Inc. D/B/A Source MDX The application has been assigned to Genomic Health Inc.

3 May 2012 Alteration of Name

The name of the applicant has been altered to Genomic Health, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.